The TECNIS ® portfolio also delivers more image contrast - day and night - than the leading competitor platform 14, 19 ‡‡‡ and more stability to stand the test of time. The TECNIS ® platform uses a proprietary combination of materials and design to deliver more for patients – more clarity with lower reflectance/lower dispersion vs competitor platform, 13,14, 15‡, the lowest level of chromatic aberration available on the market 16‡‡, and almost complete elimination of spherical aberration. The full TECNIS Synergy™ IOL family will be available across North America this summer.Īt Johnson & Johnson Vision, quality begins with the platform. The TECNIS Synergy™ IOL was first launched in Europe and Asia Pacific in 2019 and is currently available in Latin America and Canada. “Additionally, we’ll offer TECNIS Synergy™ IOL on our new Toric II platform, when it launches later this year, to give surgeons the ability to address astigmatism at the time of surgery.” “The TECNIS Synergy™ IOL combines the best of extended depth of focus and multifocal technologies – to deliver the widest range of continuous vision with the best near vision among leading PCIOLs, 3,4,6, 7† without the visual gaps caused by existing trifocal technology,” ††† said Rajesh Rajpal, Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision. Over the past year, the company has received clearance or approval across North America for seven innovations designed to be used in the treatment of cataract patients, including the TECNIS Eyhance™ IOLs. The TECNIS Synergy™ and TECNIS Synergy™ Toric II IOLs are among the latest surgical vision innovations from Johnson & Johnson Vision to receive FDA and Health Canada approval. “Having used the TECNIS ® Toric II platform in other TECNIS ® lenses, I’m eager to use the TECNIS Synergy™ Toric II IOL in patients that require astigmatism correction.” Ike Ahmed,*** Assistant Professor and Director of the Glaucoma and Advanced Anterior Surgical Fellowship, University of Toronto in Canada. “In the past 10 months of implanting the TECNIS Synergy™ IOL lens, I have seen excellent visual performance at all distances, and in a wide variety of lighting conditions, with most patients achieving freedom from glasses,” said Dr. ![]() 12 The rapid shift to digital platforms has increased demand from cataract patients for high-quality vision, from distance-to-intermediate-to-near, in all lighting conditions. 11 Over the last two decades, cataract patients’ visual needs have dramatically changed as digital devices have become an integral part of their daily lives. 9††Ĭataracts are the leading cause of preventable blindness worldwide, impacting more than 100 million eyes, 10 with more than 90% of people developing cataracts by the age of 65. 1,2,3,4,8 In a company sponsored study, 9 out of 10 patients who received TECNIS Synergy™ IOL lenses did not need glasses after surgery. This next-generation PCIOL is built on the legacy TECNIS ® platform and delivers the widest range of continuous vision with the best near vision among leading PCIOLs, 3,4,6,7,8 † superior contrast even in low-light conditions, and reduced spectacle wear. ![]() Food and Drug Administration (FDA) approval of TECNIS Synergy™ and TECNIS Synergy™ Toric II IOLs, and the Health Canada approval of TECNIS Synergy™ Toric II IOLs. ![]() SANTA ANA, CA – – Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today announced the U.S. ![]() In a company sponsored study, 9 out of 10 patients who received TECNIS Synergy™ IOL lenses did not need glasses after surgery. Next-generation presbyopia-correcting intraocular lens (PCIOL) offers continuous vision for cataract patients across every distance regardless of lighting conditions 1,2,3,4†
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |